Superdrol

Methyldrostanolone — Superdrol 10mg by Dragon Pharma

Superdrol is Dragon Pharma's formulation of oral Methyldrostanolone at 10mg per tablet — effectively a 17-alpha-methylated version of Masteron (Drostanolone), inheriting Masteron's non-aromatising, DHT-derived profile while gaining oral bioavailability through the 17-alpha-methylation. With an anabolic ratio of 400 and androgenic ratio of only 20, Superdrol produces exceptional anabolic gains per unit of androgenic activity — delivering rapid, dry mass gains without water retention while carrying the significant hepatotoxicity that defines all 17-alpha-alkylated oral steroids.

Also searched as: Superdrol 10mg, Methyldrostanolone oral, Methasterone, Superdrol Dragon Pharma.

What Superdrol Is — Methylated Masteron

The chemical relationship between Superdrol and Masteron is a genuine information gap that explains Superdrol's entire pharmacological profile:

• Masteron (Drostanolone) is a DHT-derived injectable AAS — it does not aromatise (no estrogen conversion), has high androgenic activity in its injectable form, and is used for hardness and cutting
• Superdrol adds a 17-alpha-methyl group to the Drostanolone molecule — this modification creates oral bioavailability by protecting the compound from first-pass hepatic metabolism, while simultaneously creating the hepatotoxicity associated with all 17-AA compounds
• Because the base compound (Drostanolone) is a DHT derivative that does not aromatise, adding the methyl group does not change this property — Superdrol also does not aromatise, producing the dry gains it is known for
• The 17-alpha-methyl group dramatically increases the compound's anabolic activity at the androgen receptor beyond Drostanolone alone — Superdrol's anabolic ratio (400) far exceeds Masteron's (62), while the androgenic ratio (20) remains relatively low — producing the high anabolic-to-androgenic profile that makes it unusually effective for an oral

The "Prohormone" History — Superdrol Before Scheduling

Superdrol has a unique documented history as a legal supplement that competitor content rarely covers adequately:

• Methyldrostanolone was first synthesised in the 1950s and appeared briefly in early literature but was never commercialised as a prescription drug at the time
• In 2005, it was introduced to the US supplement market as "Super-Randro" and subsequently "Superdrol" by Designer Supplements — marketed as a "prohormone" dietary supplement, leveraging a regulatory gap where specific synthetic steroids were not yet scheduled
• Superdrol became notorious among bodybuilders in 2005-2006 for its potency — user reports described it as producing more dramatic dry mass gains than any legal supplement previously available, with multiple reports of significant liver toxicity
• It was added to the Controlled Substances Act in 2012 when the Anabolic Steroid Control Act was expanded. Unlike some other prohormone compounds, Superdrol's brief legal commercial availability generated documented real-world user data from healthy individuals, providing a practical safety and efficacy profile

Superdrol vs Other Dry Oral Mass Compounds

Effects and Benefits

• Rapid dry lean mass gains — 5-10kg in a typical 4-week Superdrol cycle is commonly reported
• Significant strength increases — typically faster and larger than Dianabol at equivalent anabolic doses
• No aromatisation — no water retention, no AI required
• High anabolic-to-androgenic ratio (400:20) — less androgenic side effects than equivalent anabolic effect from testosterone
• No estrogenic gynecomastia from Superdrol itself

Dosage and Administration

Superdrol's ~8-12 hour half-life allows once or twice daily dosing. The 10mg tablet can be taken whole for 10mg/day starting dose or used as 20mg (two tablets) for the standard dose. Strict 4-week maximum due to severe hepatotoxicity — liver enzyme monitoring before and after use is essential. Never stack with other 17-AA hepatotoxic orals. For the injectable alternative with reduced first-pass hepatic load, see the Superdrol Injectable.